- Joined
- Mar 11, 2006
- Messages
- 121
- Reaction score
- 0
I took a class yesterday on cardiac support devices. I learned a lot. Pretty interesting stuff. We infrequently get VADs about 1 every other year so it's a big deal to us when we do. Does anybody work with them more frequently in a transplant center? It just blows my mind that they can be up walking around pushing the plastic ventricle that's pumping for the heart.
It seems that they would be much more challenging patients to treat for a variety of reasons. We give volume based on a set ideal range of CVP/PAD, I'd be nervous to give the amounts of volume they were talking to these guys without looking at the numbers especially if they only had a uni VAD in place. But, the way the rep explained it, it's a preload driven system, so they have to have the volume for the bladders to empty and fill to pump to systemic circulation. The clotting/anticoagulation meds/bleeding would be a difficult balance I would think also.
I was also surprised to hear the rep say that "partial support devices" ie inotropes and IABPs only boost CO by about 20%, I would have thought the IABP to be higher than that. Her point was that if you've had one failed off pump run, give it 30 minutes and try some Dob, two failed pump runs, go no longer than an hour total off pump trial (including 30 minutes above) with IABP, if that's not working, then they recommend placing a VAD. This was a new thought for me too, since if that was the guideline, we'd see a lot more VADs than what we do now. It made me wonder if some of our IABPs we see do so crappy shouldn't be considered more seriously for a VAD. She said the company is trying to switch mentality from a last ditch effort to place a VAD more to a use it early with success. What are the trends everywhere else?
It seems that they would be much more challenging patients to treat for a variety of reasons. We give volume based on a set ideal range of CVP/PAD, I'd be nervous to give the amounts of volume they were talking to these guys without looking at the numbers especially if they only had a uni VAD in place. But, the way the rep explained it, it's a preload driven system, so they have to have the volume for the bladders to empty and fill to pump to systemic circulation. The clotting/anticoagulation meds/bleeding would be a difficult balance I would think also.
I was also surprised to hear the rep say that "partial support devices" ie inotropes and IABPs only boost CO by about 20%, I would have thought the IABP to be higher than that. Her point was that if you've had one failed off pump run, give it 30 minutes and try some Dob, two failed pump runs, go no longer than an hour total off pump trial (including 30 minutes above) with IABP, if that's not working, then they recommend placing a VAD. This was a new thought for me too, since if that was the guideline, we'd see a lot more VADs than what we do now. It made me wonder if some of our IABPs we see do so crappy shouldn't be considered more seriously for a VAD. She said the company is trying to switch mentality from a last ditch effort to place a VAD more to a use it early with success. What are the trends everywhere else?